Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Solutions
  2. Products
  3. Insights
  4. About
  5. Careers
  6. Contact Us
MAIN/search
MAIN/Solutions
Solutions/
SOLUTIONS
  • Research & Development
  • Real World Evidence
  • Commercialization
  • Safety & Regulatory Compliance
  • Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
THERAPEUTIC AREAS

Impacting People's Lives

"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.

LEARN MORE
Harness the power to transform clinical development

Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.

Research & Development Overview
Research & Development Quick Links
Real World Evidence. Real Confidence. Real Results.

Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.

REAL WORLD EVIDENCE OVERVIEW
Real World Evidence Quick Links
See markets more clearly. Opportunities more often.

Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.

COMMERCIALIZATION OVERVIEW
Commercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.

Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.

COMPLIANCE OVERVIEW
Safety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.

When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.

TECHNOLOGIES OVERVIEW
Technology Quick Links
MAIN/Products
Products/
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
REAL WORLD PRODUCTS

CASE STUDY

"Data in a Day

LEARN MORE
MAIN/Insights
Insights/
BLOGS, WHITE PAPERS & CASE STUDIES

Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.

DISCOVER INSIGHTS
THE IQVIA INSTITUTE

An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.

SEE LATEST REPORTS

INSTITUTE REPORT

"Global Trends in R&D 2024

READ MORE

EMEA Insights

"IQVIA thought leadership with a focus on EMEA.

Learn more

WHITE PAPER

"DCTs Deliver Big ROI

LEARN MORE

WHITE PAPER

"Capturing value at scale: The $4 billion RWE imperative

LEARN MORE
MAIN/About
About/
FEATURED INNOVATIONS
  • IQVIA Connected Intelligence™
  • IQVIA Healthcare-grade AI™
  • Human Data Science Cloud
  • IQVIA Innovation Hub
  • Decentralized Trials
  • Patient Experience powered by Apple
WHO WE ARE
NEWS & RESOURCES

INVESTOR RELATIONS

"Visit our investor relations site for more information.

LEARN MORE
Unlock your potential to drive healthcare forward

By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.

LEARN MORE
IQVIA AI is Healthcare-grade AI

Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.

LEARN MORE
Your healthcare data deserves more than just a cloud.

The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.

LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships

The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.

LEARN MORE
Proven, faster DCT solutions

IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.

LEARN MORE
IQVIA Patient Experience Solutions powered by Apple

Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm. IQVIA and Apple are collaborating to bring this exciting future of personalized care directly to devices patients already have and use.

LEARN MORE
MAIN/Careers
Careers/
WORKING AT IQVIA

Our mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.

LEARN MORE
LIFE AT IQVIA

Careers, culture and everything in between. Find out what’s going on right here, right now.

LEARN MORE

WE’RE HIRING

"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.

SEARCH JOBS
MAIN/Contact Us
Contact Us/

Press Release

The Vall d'Hebron Campus signs a Prime Site Agreement with IQVIA, the world's largest clinical trials management company

avr. 24, 2018
  • Thanks to the agreement, any trial carried out by IQVIA will be offered to Vall d'Hebron
  • IQVIA is the main promoter of clinical research in Vall d'Hebron. During 2017 it managed 115 of the 1,015 trials in which the Hospital participated
  • Vall d'Hebron is consolidated as well as a leading center in the conduct of clinical trials, both for the volume and the complexity of its design

The Vall d'Hebron Barcelona Hospital Campus and IQVIA, the largest Contract Research Organization (CRO) worldwide, have signed a preferential collaboration agreement (Prime Site Agreement), according to which both institutions commit to work together in the realization of clinical trials in a framework of excellence for the benefit of the patient and all related agents. Through this agreement, the first with a hospital in southern Europe and one of the only 16 that have been signed throughout Europe, IQVIA will offer Vall d'Hebron, as a priority or preferential, any clinical trial managed by the American company.

During 2017, Vall d'Hebron participated in 1,015 clinical trials. A total of 115 (around 11%) were managed by IQVIA, which makes it the main promoter of commercial clinical research in the Campus. Among the trials managed by the Vall d'Hebron Institute of Research (VHIR) and the Vall d'Hebron Institute of Oncology (VHIO), 61 belonged to the area of Oncology in adults and the remaining 54, to areas such as Neurology (23), Internal Medicine (14) or Pediatrics (9), among others. A win-win alliance Vall d'Hebron is consolidated as well as a leading center in the conduct of clinical trials, both for the volume and the complexity of its design. And the main beneficiaries are the patients who will have more opportunities to access therapies and treatments not yet available. But also, professionals who acquire knowledge and professional projection. In addition, the Vall d'Hebron Campus increases its visibility, its positioning and, most importantly, its ability to attract talent. For Dr. Vicenç Martínez Ibáñez, Vall d'Hebron Hospital Manager, the agreement means "strengthening the Campus's leadership in clinical trials, as well as our alliance with a global giant such as IQVIA".
IQVIA is a Contract Research Organization, a mediating / managing company between pharmaceutical companies and hospitals for clinical trials. It works with the big pharmaceutical companies that promote the most advanced, innovative and complex trials. Result of the merger between IMS Health and Quintiles, IQVIA allows companies to approach clinical development and commercialization from an innovative perspective, as well as accelerate the achievement of significant results in health care. According to Laura Sánchez, IQVIA Senior Director Site Management, "it is an agreement to work more closely, to collaborate in more studies, get good data and take the medicines to patients as soon as possible. This agreement involves the assignment of an IQVIA (Prime Site Manager) manager, dedicated to the hospital one hundred percent. "

IQVIA is forming several therapeutic networks to attract more studies to Spain, in which Vall d'Hebron already participates or will participate. These are networks such as the Early Phase Oncology Network, a network in Pediatrics and Rare Diseases, in Alzheimer's Disease, NASH and Ophthalmology and a network in Early Phases in Psychiatry.

"A month ago, we signed the first contract for an academic study with the VHIO and, from this promising start, our intention is to create a unit within IQVIA that allows us to offer the possibility of doing these studies, so important in the development of the new drugs, in other therapeutic areas ", said Laura Sánchez.

With this agreement, IQVIA can guarantee to pharmaceutical companies that clinical trials are carried out in a reference and prestige center, with recognized professionals and with a consolidated structure for the development of biomedical research.

For the Dr, Josep Tabernero, director of the VHIO, "this strategic alliance between IQVIA and the Campus Vall d'Hebron represents a further advance in the lines of research of Precision Medicine in all areas of Medicine as a continuation of the development that we already had cancer areas, especially in the early development of new drugs".

For his part, Dr. Joan Comella, director of VHIR, said that "bring the medicine of the future (the use of gene therapy or stem cells, among others), through partnerships between the best".

The will of the Vall d'Hebron Campus goes beyond the signing of this Prime Site Agreement and raises the possibility of exploring other areas of joint work with IQVIA, such as the development of training actions or patronage projects.

Contact Us